2195 results about "Electrocardiography" patented technology

A non-invasive physiologic signs monitoring device includes a garment with electrocardiogram electrodes and various inductive plethysmographic sensors sewn, embroidered, embedded, or otherwise attached to the garment with an adhesive. The garment is in the form of a shirt. When the garment is fitted over the torso of the patient to be monitored, the electrodes and sensors generate signals in response to the physiologic signs of the patient. The signals are transmitted to a recording/alarm device where they are monitored for adverse conditions and logged. When an adverse condition or other preprogrammed condition occurs, a message is communicated to the patient by either an audio message or a display. The recording/alarm unit is also connectable to a remote receiving unit for monitoring by a health care professional or other machine.

A system for monitoring a patient's vital signs that features a vital-sign monitor including sensors for measuring from the patient at least one of the following vital-sign data: O₂ saturation, blood pressure, electro-cardiogram, respirator rate, and blood glucose level. The system also includes a global positioning system that determines location-based data. A wireless transmitter, in electrical contact with the vital-sign monitor and global positioning system, receives the vital-sign and location-based data and wirelessly transmits these data through a conventional wireless network. A gateway software piece receives and processes the data from the wireless network and stores these data in a computer memory associated with a database software piece. The system also includes an Internet-based user interface that displays the vital sign data for both individual patients and care-providers.

A water and moisture sealed, self contained, compact, long term, ambulatory physio-kinetic monitor is designed for mounting directly to the skin of an athlete or fitness performer, preferably immediately adjacent to the organ or system that is to be monitored, and is adhesively held there in place, covertly and comfortably, under clothing by disposable electrode, adhesive skin pads. At least three positive electrodes and a common negative electrode extend from the monitor and attach by similar disposable adhesive electrode pads to detect physiological, e.g. ECG data. Accelerometer means disposed within the monitor detects body movement and likewise stores that data on a third ECG data channel.

The invention provides a disposable programmable ECG sensor patch for the non-invasive detection of risk patterns according to programmed criteria. The patch is programmed by a medical professional to select one or more monitoring parameters for detection and alarm indication. One application is to detect changes in the ECG due to cardioactive drugs. Another application is triggering an alarm for a cardiac patient during a stress condition. The programmable patch operates in conjunction with an external programming unit for selecting the detection monitoring parameters.

The invention provides a disposable sensor patch for non-invasive monitoring and recording of infrequent cardiac events. The patch is thin and flexible for comfortable wear on the person's chest for automatic analysis and recording of ECG. The patch is inexpensive and simple for self-administration. The patch incorporates a battery, ECG amplifier, and a processor for analyzing ECG waveform and recording events. A software algorithm searches for a cardiac abnormality. The patch is designed for continuous long-term wear exceeding 3 days for diagnostic monitoring and exceeding 14 days for event detection. In one embodiment a preformatted report is automatically generated by the patch for wireless transmission to a reporting device such as a generic printer or a wireless network system. The patch may also incorporate a marker switch to correlate recorded ECG data with the patient's perception of a cardiac event.

A portable, integrated physiological monitoring system is described for use in clinical outpatient environments. This systems consists of a plethora of sensors and auxiliary devices, an electronics unit (100) that interfaces to the sensors and devices, and a portable personal computer (102). Electrodes (106) are provided to acquisition electrocardiographic, electroencephalographic, and neuromuscular signals. Electrodes (108) are provided to stimulate neural and muscular tissue. A finger pulse oximeter (110), an M-mode ultrasonic transducer (112), an airflow sensor (114), a temperature probe (120), a patient event switch (116), and an electronic stethoscope (118) are provided. A portable personal computer (102) interfaces to the electronics unit (100) via a standard parallel printer port interface (258) to allow communication of commands and information to/from the electronics unit (100). Control and display of the information gathered from the electronics unit (100) is accomplished via an application program executing on the portable personal computer (102). Sharing of common data acquisition hardware along with preliminary processing of information gathered is accomplished within the electronics unit (100). The entire system is battery operated and portable. This system, because of its architecture, offers significant cost advantages as well as unique modes of operation that cannot be achieved from the individual physiological parameter measurement devices alone. The system allows for the integration of acquisitioned information from the sensors into a patient's database stored on the portable personal computer.

A cardiac monitor is provided that monitors the condition of the heart of a cardiac patient and generates signals indicating one of several conditions, such as supraventricular tachycardia, ventricular tachycardia and ventricular fibrillation. In order to generate these signals, the ECG from the patient is analyzed to determine a cardiac interval and heart rate, as well as a waveform factor and a waveform factor irregularity. The waveform factor is derived from the average of the ECG amplitudes during a cardiac interval and the peak value of the ECG during the same interval. Preferably, a running average is calculated over several intervals. This waveform factor is then used to detect shockable ventricular arrhythmia. The waveform factor irregularity is indicative of the variability of the waveform factor and is used to differentiate between ventricular tachycardia and ventricular defibrillation.

A wrist-mounted device (100) for measuring at least one physiological parameter of the user. The present invention enables such a measurement to preferably be transformed into clinically useful information about the user. Such information may then optionally be sent to medical personnel, for example at a contact and/or monitoring center. The measuring parameters may include blood pressure, ECG, location. The present invention can perform a Holter process over more than one physiological parameter.

A system to form and store an electrocardiogram (ECG) signal derived from a cardiac electrical signal that includes an apparatus having a pair of the electrodes to connect to a patient to detect the cardiac electrical signal. A signal sampler samples the cardiac electrical signal to form the ECG signal. A data storage device stores the ECG signal. A computer communicates with the data storage device to retrieve the ECG signal for analysis by software stored in the memory of the computer. The software analyzes a morphology of the amplitude of a plurality of R-wave peaks contained within the ECG signal and/or analyzes a morphology of the area of a plurality of QRS complex pulses contained within the ECG signal.

Systems and methods of detecting an impending cardiac decompensation of a patient measure an electrocardiogram signal of the patient. An incidence of cardiac arrhythmias is determined from the electrocardiogram signal. A risk of impending decompensation is determined in response to the incidence of cardiac arrhythmias. In many embodiments, the impending decompensation can be detected early enough to avoid, or at least delay, the impending decompensation, such that patient trauma and/or expensive ICU care can be avoided. Although embodiments make specific reference to monitoring electrocardiogram and other physiological signals with an adherent patch, the system methods and devices are applicable to many applications in which physiological monitoring is used, for example wireless physiological monitoring with implanted sensors for extended periods.

A wristwatch worn by a user for measuring three-lead ECG is disclosed. The wristwatch includes three electrodes placed separately on the front, either side, and back or strap thereof. The wristwatch further includes an electrode panel having the electrode on the front or either side of the watch, sensing elements, pressure, infrared or impedance detectors, and circuits. The electrode panel is capable of sensing the contact or press of fingers to trigger ECG measuring. While the electrode in the back-side of the watch contacts the hand wearing the watch, the electrode and electrode panel on the front or either side of the watch are pressed by fingers from the other hand and the electrode in the strap contacts abdomen or left leg simultaneously, three-lead ECG can be measured. ECG data can be transmitted to a personal or hospital computer by wireless networks or flash memory.

An ECG electrode chest pad particularly adapted for use in emergency room situations having upper fit portions with upper limb electrodes, and elongated central or medial base fit portion with a plurality of precordal unipolar electrodes and lower fit portions with lower limb electrodes, said electrodes being attached to leads which are internal to the base chest pad and terminate into at least one lead branch adapted to plug into an ECG monitor and having a perforation in the base pad material such that one group of electrodes may be separated from a second group of electrodes to facilitate ease of patient monitoring and complimentary medical procedures.

A method of analyzing electrocardiogram (EKG) data for use in the diagnosis of heart disease, prognosis of cardiac conditions, and the monitoring of heart disease therapies is disclosed. The method utilizes a wavelet-based multifractal analysis with one or more of (1) a discrete wavelet smoothing step to remove the effects of abnormal beats; (2) “Levy flight” analysis to detect the frequency of abnormal beats known to adversely affect the multifractal (MF) analysis; and (3) MF alpha analysis, a multifractal extension of monofractal short term (ST) alpha analysis. The invention further comprises an EKG test battery comprising Levy flight anomalous beat/beat cluster screening, followed by (ST) MF alpha analysis and MF Holder analysis (when validated by the Levy flight analysis). The wavelet smoothing step can also be used to classify human EKGs by observing the effect of sequential smoothing on the MF Holder coefficient. Alternative choices to the wavelet smoothing approach to removal of abnormal beat effects include probability distribution function analysis to determine the MF Holder coefficient directly, abnormal beat ridge skeleton removal to remove the offending beats based on a direct multifractal spectrum calculation, and the calculation of various types of entropy coefficients for the EKG time series.

A method and system (30, 50) for predicting the immediate success of a defibrillatory shock during cardiac arrest are shown. The sequencing of cardiopulmonary resuscitation is determined by an electronic computer (80) based on the probability of success as determined by a comparison of the amplitude spectrum area or the power spectrum area of an electrocardiogram sample and to empirical data. When the probability of successful resuscitation is 80% or greater, immediate defibrillation is implemented. When the probability of success is 20% or less, advanced cardiopulmonary resuscitation is implemented. When the probability of success remains greater than 20% but less than 80% for a period of four minutes, the patient is also defibrillated.

A body-worn sensor that measures respiratory rate and other vital signs using an acoustic sensor (e.g., a small-scale sensor). The body-worn sensor features a chest-worn patch sensor that combines both the acoustic sensor and an ECG electrode into a single adhesive patch. To measure blood pressure, the device additionally performs a ‘composite’ PTT-based measurement that features both pressure-dependent and pressure-free measurements. The acoustic sensor measures respiration rate by recording sounds related to the patient's inspiration and expiration. The acoustic sensor is typically placed near the patient's trachea, but can also be placed on the middle right and left side of the chest, and the middle right and left side of the back.

The method of presenting concurrent information about the electrical and mechanical activity of the heart using non-invasively obtained electrical and mechanical cardiac activity data from the chest or thorax of a patient comprises the steps of: placing at least three active Laplacian ECG sensors at locations on the chest or thorax of the patient; where each sensor has at least one outer ring element and an inner solid circle element, placing at least one ultrasonic sensor on the thorax where there is no underlying bone structure, only tissue, and utilizing available ultrasound technology to produce two or three-dimensional displays of the moving surface of the heart and making direct measurements of the exact sites of the sensors on the chest surface to determine the position and distance from the center of each sensor to the heart along a line orthogonal to the plane of the sensor and create a virtual heart surface; updating the measurements at a rate to show the movement of the heart's surface; monitoring at each ultrasonic sensor site and each Laplacian ECG sensor site the position and movement of the heart and the passage of depolarization wave-fronts in the vicinity; treating those depolarization wave-fronts as moving dipoles at those sites to create images of their movement on the image of the beating heart's surface; and, displaying the heart's electrical activity on the dynamically changing image of the heart's surface with the goal to display an approximation of the activation sequence on the beating virtual surface of the heart

Disclosed are systems and methods which provide a relatively small, preferably easily transportable, interpretive biotelemetric monitor, such as may utilize platforms developed for use as personal digital assistants, adapted for use by non-health care personnel. A preferred embodiment biotelemetric monitor comprises a self-contained EKG monitor providing ICU cardiac monitoring with accurate real-time diagnostic heart rhythm analysis directly to the wearer. Preferred embodiment biotelemetric monitors implement multiple interactive screens to guide a user through a series of screens to help understand the monitored conditions. Moreover, the biotelemetric monitor may operate to analyze and interpret the monitored data to thereby present information with respect to the probable implications of the monitored condition and/or make recommendations which may be useful to the patient at that time. Preferably, communications functionality is included to facilitate communication between the biotelemetric monitor and a host system.

A depolarization waveform classifier based on the Modified lifting line wavelet Transform is described. Overcomes problems in existing rate-based event classifiers. A task for pacemaker/defibrillators is the accurate identification of rhythm categories so correct electrotherapy can be administered. Because some rhythms cause rapid dangerous drop in cardiac output, it's desirable to categorize depolarization waveforms on a beat-to-beat basis to accomplish rhythm classification as rapidly as possible. Although rate based methods of event categorization have served well in implanted devices, these methods suffer in sensitivity and specificity when atrial/ventricular rates are similar. Human experts differentiate rhythms by morphological features of strip chart electrocardiograms. The wavelet transform approximates human expert analysis function because it correlates distinct morphological features at multiple scales. The accuracy of implanted rhythm determination can then be improved by using human-appreciable time domain features enhanced by time scale decomposition of depolarization waveforms.

A system that includes a mobile platform and a remote station. The remote station may be a personal computer coupled to the remote platform through a broadband network. A user can control movement of the mobile platform through the remote station. A medical monitoring device such as a stethoscope or EKG monitor can be coupled to the mobile platform and used to take patient data. The data can be transmitted to the remote station by the mobile platform. The medical monitoring device(s) may be wirelessly coupled to the mobile platform. The system may include a server that can provide an electronic medical record to the remote station. The remote station may have a monitor that displays the electronic medical record and an image captured by a camera of the mobile platform. The system allows a doctor at the remote station to more fully examine a patient while viewing past medical records.

An implantable cardiac rhythm management device operable in an autothreshold or autocapture verification mode, wherein the rhythm management device is capable of detecting noise that affects signal characteristics of a sensed intracardial evoked response electrogram signal. The device includes a noise detection circuit that determines whether a minimum peak timing occurs during a predetermined time following delivery of a stimulation pulse. If a minimum peak timing occurs during the predetermined time following delivery of the stimulation pulse, then significant amounts of noise affecting the signal characteristics of the electrocardiogram signal is assumed.

Methods for sensing or electrical stimulation of body organs or tissues are disclosed wherein a lead conductor wire or filament of a stranded lead conductor generates a radioactive emission when it is fractured sufficiently or is completely broken. The conductor wire or filament is formed of an inner core and an outer sheath surrounding the inner core, wherein the inner core is irradiated or is formed of a radioactive isotope in an alloy that provides an enhanced radiopaque aura when the sheath is fractured and the inner core is exposed. When the conductor wire or filament is intact, the radioactive inner core is fully encased within the outer sheath, and the outer sheath blocks or reduces radioactive emission along its length to a constant, relatively low level. In use, the emission is detected externally to the body, and the detection signifies that a fracture or break has occurred. Such leads preferably comprise cardiac leads for delivering electrical stimulation to the heart, e.g., pacing pulses and cardioversion/defibrillation shocks, and/or sensing the cardiac electrogram, having multiple lead conductors encased in a lead body subject to fracture under stress. The lead conductors can comprise mono-filar or multi-filar, parallel wound, coiled wires that arranged in a co-axial manner or in a side-by-side arrangement within the lead body. Or the straight or coiled lead conductors can be formed of a strand comprising a plurality of outer filaments wound helically about a central core filament or of a cable comprising a plurality of such peripheral strands wound helically about a central core strand. At least the outer filaments of a stranded conductor and peripheral strands of a conductor cable are formed with the radioactive core.

Cardiac monitoring and/or stimulation methods and systems provide for monitoring, diagnosing, defibrillation and pacing therapies, or a combination of these capabilities, including cardiac systems incorporating or cooperating with neuro-stimulating devices, drug pumps, or other therapies. Embodiments of the present invention relate generally to implantable medical devices employing automated cardiac activation sequence monitoring and/or tracking for arrhythmia discrimination. Embodiments of the invention are directed to devices and methods involving sensing a plurality of composite cardiac signals using a plurality of implantable electrodes. A source separation is performed using the sensed plurality of composite cardiac signals and the separation produces one or more cardiac signal vectors associated with one or more cardiac activation sequences that is indicative of ischemia. A change of the one or more cardiac signal vectors is detected using the one or more cardiac signal vectors. Cardiac arrhythmias are discriminated using the one or more cardiac signal vectors.